Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options

During the past decade, the age-adjusted mortality rate for endometrial cancer (EC) increased 1.9% annually with TP53 mutant (TP53-mu) EC disproportionally represented in advanced disease and deaths. Therefore, we aimed to assess pivotal molecular parameters that differentiate clinical outcomes in h...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS One
Asıl Yazarlar: Bosquet, Jesus Gonzalez, Zhang, Qing, Cliby, William A., Bakkum-Gamez, Jamie N., Cen, Ling, Dowdy, Sean C., Sherman, Mark E., Weroha, S. John, Clayton, Amy C., Kipp, Benjamin R., Halling, Kevin C., Couch, Fergus J., Podratz, Karl C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2021
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7840025/
https://ncbi.nlm.nih.gov/pubmed/33503056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0245664
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller